22157.jpg
Insights on the Diabetes Devices and Drugs Global Market to 2026 - Rapidly Changing Lifestyles are Driving Growth
15 juil. 2021 05h33 HE | Research and Markets
Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026" report has been added to...
22157.jpg
Global Needle Free Diabetes Management Market (2021 to 2029) - Featuring Injex Pharma, Medtronic and Johnson & Johnson Among Others
05 mai 2021 06h28 HE | Research and Markets
Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Needle Free Diabetes Management Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
22157.jpg
Worldwide Industry for Blood Glucose Monitoring Consumables to 2026 - Increasing Demand for Test Strips & Lancets Due To COVID-19
15 avr. 2021 06h08 HE | Research and Markets
Dublin, April 15, 2021 (GLOBE NEWSWIRE) -- The "Blood Glucose Monitoring Consumables Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The...
AMR Logo.png
Self-Monitoring Blood Glucose Devices Market to Reach $11.9 Billion at 4.2% CAGR by 2027
04 nov. 2020 10h00 HE | Allied Market Research
Portland, OR, Nov. 04, 2020 (GLOBE NEWSWIRE) -- According to a new report published by Allied Market Research, titled, "Self-monitoring Blood Glucose Devices Market by Product, Application, and End...
22157.jpg
Worldwide Continuous Glucose Monitoring Device Industry to 2026 - Key Drivers and Restraints of the Market
31 août 2020 05h04 HE | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Global Continuous Glucose Monitoring Device Market By Component, By End User, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been...
Reports and Data.jpeg-01
Continuous Glucose Monitoring Devices Market To Reach USD 1.25 Billion By 2026 | Reports And Data
11 nov. 2019 21h30 HE | Reports and Data
New York, Nov. 11, 2019 (GLOBE NEWSWIRE) -- High incidence of diabetes, increasing geriatric population & continuous technological advancements across the globe are the key factors contributing...
AMI.jpg
UPDATE - Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
07 mars 2019 07h01 HE | Absolute Markets Insights
PUNE, India, March 07, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
AMI.jpg
Global Artificial Intelligence in Diabetes Management Market is Expected to Grow at a CAGR of 37.7% in 2019-2027: Absolute Markets Insights
06 mars 2019 07h29 HE | Absolute Markets Insights
PUNE, India, March 06, 2019 (GLOBE NEWSWIRE) -- Type 2 diabetes is a chronic condition in which an individual is unable to produce or use insulin well, that subsequently results in elevated blood...
InSpark Technologies
InSpark Technologies Announces the Results of the Home Use and Human Factors Study of Vigilant(TM) in People with Diabetes
11 juin 2016 11h00 HE | InSpark Technologies
Vigilant met or exceeded all human factors criteria for safety, comprehension and ease of useEarly evidence of clinical benefit was demonstrated by a 51 percent reduction in the proportion of blood...
Cellnovo logo
Cellnovo Wins BIOVISION Investor Conference Award
11 juin 2014 09h10 HE | Cellnovo
SWANSEA, UK, June 11, 2014 (GLOBE NEWSWIRE) -- Cellnovo, the leading innovator in mobile diabetes management, announced today that the Company has received the BIOVISION Investment Conference 2014...